Age reprogramming: cell rejuvenation by partial reprogramming
'Age reprogramming' refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced...
Uloženo v:
| Vydáno v: | Development (Cambridge) Ročník 149; číslo 22 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
15.11.2022
|
| Témata: | |
| ISSN: | 1477-9129, 1477-9129 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | 'Age reprogramming' refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripotent stem cells, which involves passage through an embryonic stage and loss of cellular identity. Accordingly, the study of age reprogramming can provide an understanding of how ageing can be reversed while retaining cellular identity and the specialised function(s) of a cell, which will be of benefit to regenerative medicine. Here, we highlight recent work that has provided a more nuanced understanding of age reprogramming and point to some open questions in the field that might be explored in the future. |
|---|---|
| AbstractList | 'Age reprogramming' refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripotent stem cells, which involves passage through an embryonic stage and loss of cellular identity. Accordingly, the study of age reprogramming can provide an understanding of how ageing can be reversed while retaining cellular identity and the specialised function(s) of a cell, which will be of benefit to regenerative medicine. Here, we highlight recent work that has provided a more nuanced understanding of age reprogramming and point to some open questions in the field that might be explored in the future.'Age reprogramming' refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripotent stem cells, which involves passage through an embryonic stage and loss of cellular identity. Accordingly, the study of age reprogramming can provide an understanding of how ageing can be reversed while retaining cellular identity and the specialised function(s) of a cell, which will be of benefit to regenerative medicine. Here, we highlight recent work that has provided a more nuanced understanding of age reprogramming and point to some open questions in the field that might be explored in the future. 'Age reprogramming' refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripotent stem cells, which involves passage through an embryonic stage and loss of cellular identity. Accordingly, the study of age reprogramming can provide an understanding of how ageing can be reversed while retaining cellular identity and the specialised function(s) of a cell, which will be of benefit to regenerative medicine. Here, we highlight recent work that has provided a more nuanced understanding of age reprogramming and point to some open questions in the field that might be explored in the future. |
| Author | Singh, Prim B Zhakupova, Assem |
| Author_xml | – sequence: 1 givenname: Prim B orcidid: 0000-0002-9571-0974 surname: Singh fullname: Singh, Prim B organization: Department of Medicine, Nazarbayev University School of Medicine, 5/1 Kerei Zhanibek Khandar Street, Astana 010000, Republic of Kazakhstan – sequence: 2 givenname: Assem surname: Zhakupova fullname: Zhakupova, Assem organization: Department of Medicine, Nazarbayev University School of Medicine, 5/1 Kerei Zhanibek Khandar Street, Astana 010000, Republic of Kazakhstan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36383700$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVj0tLw0AUhQep2Idu_AGSpZvUO4_MZAQXpfiCghtdh5nJNaQkkzqTFPrvG7GCbu49HD7uOXdOJr7zSMg1hSVlgt2VuF8yAJVlZ2RGhVKppkxP_ugpmce4BQAulbogUy55zhXAjDysKkwC7kJXBdO2ta_uE4dNM3rbYY_e9HXnE3tIdib0tWn-s5fk_NM0Ea9Oe0E-nh7f1y_p5u35db3apI4z3qfGYClVTrWwUjA0hkqw1jqHiC7jJndgHZajHIcUEnInALngKFED02xBbn_ujtlfA8a-aOv4XdN47IZYMMWVkEJnckRvTuhgWyyLXahbEw7F78vsCEcOWnE |
| CitedBy_id | crossref_primary_10_1186_s13287_025_04285_7 crossref_primary_10_1016_j_jbusvent_2025_106512 crossref_primary_10_1089_cell_2022_0160 crossref_primary_10_3389_fgene_2024_1389558 crossref_primary_10_3390_cells13242052 crossref_primary_10_3390_cells14161249 crossref_primary_10_14336_AD_2024_0280 crossref_primary_10_1080_15592294_2023_2252631 crossref_primary_10_3390_cells13070628 crossref_primary_10_1134_S0026893324700377 crossref_primary_10_1007_s11357_023_00949_5 crossref_primary_10_3390_genes14091697 crossref_primary_10_3390_ijms242115804 crossref_primary_10_1016_j_tem_2024_08_004 crossref_primary_10_1016_j_stem_2024_09_013 crossref_primary_10_1002_bies_202200208 crossref_primary_10_1038_s43587_023_00528_5 crossref_primary_10_1080_17501911_2024_2432851 crossref_primary_10_7554_eLife_90579_3 crossref_primary_10_7554_eLife_90579 crossref_primary_10_1016_j_arr_2024_102204 crossref_primary_10_1016_j_mocell_2024_100137 crossref_primary_10_1134_S2079057024600381 crossref_primary_10_1080_13102818_2024_2358999 crossref_primary_10_1111_acel_14039 crossref_primary_10_3390_cells13232002 crossref_primary_10_3390_ijms252312533 |
| ContentType | Journal Article |
| Copyright | 2022. Published by The Company of Biologists Ltd. |
| Copyright_xml | – notice: 2022. Published by The Company of Biologists Ltd. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1242/dev.200755 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Zoology Biology |
| EISSN | 1477-9129 |
| ExternalDocumentID | 36383700 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -ET -~X .55 0R~ 18M 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 85S AAFWJ ABJNI ABZEH ACGFS ACPRK ACREN ADBBV ADFRT ADVGF AENEX AFFNX AGGIJ ALMA_UNASSIGNED_HOLDINGS AMTXH BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF F5P F9R GX1 H13 HZ~ INIJC KQ8 NPM O9- OK1 P2P R.V RCB RHI SJN TR2 TWZ UPT W8F WH7 WOQ X7M XSW 7X8 |
| ID | FETCH-LOGICAL-c323t-aaed678194b642eaa160bbbcceeec53a8c0bcedc53edc64608c40e343e6e90292 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 28 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000894078400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-9129 |
| IngestDate | Sun Nov 09 09:36:45 EST 2025 Mon Jul 21 05:37:53 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 22 |
| Keywords | Epigenetic rejuvenation OSKM Cellular identity Partial reprogramming H3K9me3 Age reprogramming |
| Language | English |
| License | 2022. Published by The Company of Biologists Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c323t-aaed678194b642eaa160bbbcceeec53a8c0bcedc53edc64608c40e343e6e90292 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9571-0974 |
| OpenAccessLink | https://doi.org/10.1242/dev.200755 |
| PMID | 36383700 |
| PQID | 2737464956 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2737464956 pubmed_primary_36383700 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-11-15 |
| PublicationDateYYYYMMDD | 2022-11-15 |
| PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Development (Cambridge) |
| PublicationTitleAlternate | Development |
| PublicationYear | 2022 |
| SSID | ssj0003677 |
| Score | 2.5331995 |
| Snippet | 'Age reprogramming' refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| SubjectTerms | Cellular Reprogramming - genetics Epigenesis, Genetic Induced Pluripotent Stem Cells Regenerative Medicine Rejuvenation |
| Title | Age reprogramming: cell rejuvenation by partial reprogramming |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36383700 https://www.proquest.com/docview/2737464956 |
| Volume | 149 |
| WOSCitedRecordID | wos000894078400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UqnjxUV_1RQSvSzfZzWYjiBSxeLClB5XipewromhS7QP6753dpBQPguBlCUMCy2R2vtl5InRhMpkwoUIcak4wA4DAwkQC89SIWFk4Yr4q7ek-6XZFv5_2KofbqEqrnOtEr6hNoZ2PvAkwmzDuzPnr4Sd2U6NcdLUaobGMahRMGSfVSX_RLZxyP3kxZC5MCcBWtScFVGoaO_Vl6HH8u2npIaa99d_NbaPNyrgMWqU07KAlm9fRWjluclZH650qkA7E58ITd9FV68UGrrWlz9P6ACS7DJw3H2hvE9CE_s8FahYMnZDJ95_v7qHH9u3DzR2uZipgTSM6xlJaA_gUpkzBzcNKGXKilNKAlVbHVApNlLYGHmHhjBOhGbGUUcttSqI02kcreZHbQxRkUigmwoy6LmdMGCU5J4m0AIbMGCob6HzOrAHIrNu6zG0xGQ0W7Gqgg5Ljg2HZXGNAubszE3L0h6-P0UbkqhFcVl58gmoZnFh7ilb1dPw6-jrzwgBrt9f5BnkBvxs |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age+reprogramming%3A+cell+rejuvenation+by+partial+reprogramming&rft.jtitle=Development+%28Cambridge%29&rft.au=Singh%2C+Prim+B&rft.au=Zhakupova%2C+Assem&rft.date=2022-11-15&rft.issn=1477-9129&rft.eissn=1477-9129&rft.volume=149&rft.issue=22&rft_id=info:doi/10.1242%2Fdev.200755&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-9129&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-9129&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-9129&client=summon |